Glaxo SmithKline plc (ADR) (NYSE:GSK) Strikes Deal On Cancer Drug Venture

Boston, MA 06/04/2014 (wallstreetpr) – Developer and manufacturer of global healthcare products, Glaxo SmithKline plc (ADR) (NYSE:GSK) has struck a deal with biotechnology and privately-held company, Adaptimmune, for the development of a drug for cancer. Cancer Drug Glaxo SmithKline’s deal with Adaptimmune is reportedly worth over $350 million that is spread over a period of […]

Abbott Laboratories (NYSE:ABT)’S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail

Boston, MA 04/21/2014 (wallstreetpr) – A spinoff of Abbott Laboratories (NYSE:ABT) insisted on a federal appeals court in San Francisco to rethink its decision in the case against Glaxo SmithKline plc (ADR) (NYSE:GSK). On Thursday, AbbVie Inc (NYSE:ABBV) urged the 9th U.S. Circuit Court of Appeals to revisit a preliminary three judge ruling according to which […]